ETFA is a critical fluorinated building block and reagent used in the synthesis of a wide range of organic fluorine compounds. These compounds find extensive applications across the life sciences, pharmaceutical, and performance materials, where fluorine chemistry plays a vital role in enhancing product performance, efficacy, and stability. The global addressable market for ETFA is estimated at approximately $500–600 million, highlighting its strategic importance within the specialty chemicals value chain.
Anupam Rasayan India Ltd has commercialised ETFA (Ethyl trifluoroacetate) production using its proprietary continuous flow chemistry platform, becoming the first company globally to manufacture the fluorinated building block at commercial scale through flow technology.
The innovation improves safety, scalability, efficiency and sustainability, targeting a global ETFA market valued at $500–600 million.
The achievement positions Anupam Rasayan India Limited as the first company globally to manufacture ETFA at commercial scale using flow technology. Compared with conventional batch processes, the continuous flow platform offers significant advantages, including enhanced process safety, superior reproducibility, improved scalability, higher operational efficiency, and a lower environmental footprint.
Speaking about the achievement, Anand Desai, Managing Director of Anupam Rasayan, said:
“The successful commercialisation of ETFA through our continuous flow chemistry platform represents a significant milestone in Anupam Rasayan’s innovation journey. This achievement not only demonstrates our technological capabilities in complex fluorination chemistry but also highlights our ability to develop and scale differentiated manufacturing solutions that address evolving customer requirements. Innovation remains at the core of our growth strategy. We will continue to invest in cutting-edge process technologies, research capabilities, and sustainable manufacturing practices to create long- term value for our customers, stakeholders, and the industry at large.”
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (JP)
